Krystal Biotech, Inc. Earnings Per Share (Basic)
Krystal Biotech, Inc. (KRYS) reported Earnings Per Share (Basic) of $1.85 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-03
- Krystal Biotech, Inc. earnings per share, basic for the quarter ending 2026-06-30 was $1.85, a 39.10% increase year-over-year.
- Krystal Biotech, Inc. earnings per share, basic for the quarter ending 2026-03-31 was $1.91, a 54.03% increase year-over-year.
- Krystal Biotech, Inc. earnings per share, basic for the quarter ending 2025-09-30 was $2.74, a 188.42% increase year-over-year.
- Krystal Biotech, Inc. earnings per share, basic for the quarter ending 2025-06-30 was $1.33, a 146.30% increase year-over-year.
- Krystal Biotech, Inc. earnings per share, basic for fiscal 2025 was $7.08, a 126.92% increase from fiscal 2024.
- Krystal Biotech, Inc. earnings per share, basic for fiscal 2024 was $3.12, a 680.00% increase from fiscal 2023.
- Krystal Biotech, Inc. earnings per share, basic for fiscal 2023 was $0.40.
- Krystal Biotech, Inc. earnings per share, basic for fiscal 2022 was -$5.49.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.85 10-Q · filed 2026-08-03 | $3.76 10-Q · filed 2026-08-03 | ||
| 2026-03-31 | $1.91 10-Q · filed 2026-05-04 | |||
| 2025-12-31 | $7.08 10-K · filed 2026-02-17 | |||
| 2025-09-30 | $2.74 10-Q · filed 2025-11-03 | $5.31 10-Q · filed 2025-11-03 | ||
| 2025-06-30 | $1.33 10-Q · filed 2026-08-03 | $2.57 10-Q · filed 2026-08-03 | ||
| 2025-03-31 | $1.24 10-Q · filed 2026-05-04 | |||
| 2024-12-31 | $3.12 10-K · filed 2026-02-17 | |||
| 2024-09-30 | $0.95 10-Q · filed 2025-11-03 | $1.53 10-Q · filed 2025-11-03 | ||
| 2024-06-30 | $0.54 10-Q · filed 2025-08-04 | $0.58 10-Q · filed 2025-08-04 | ||
| 2024-03-31 | $0.03 10-Q · filed 2025-05-06 | |||
| 2023-12-31 | $0.40 10-K · filed 2026-02-17 | |||
| 2023-09-30 | $2.88 10-Q · filed 2024-11-04 | $0.08 10-Q · filed 2024-11-04 | ||
| 2023-06-30 | -$1.25 10-Q · filed 2024-08-05 | -$3.00 10-Q · filed 2024-08-05 | ||
| 2023-03-31 | -$1.76 10-Q · filed 2024-05-06 | |||
| 2022-12-31 | -$5.49 10-K · filed 2025-02-19 | |||
| 2022-09-30 | -$1.17 10-Q · filed 2023-11-06 | -$4.24 10-Q · filed 2023-11-06 | ||
| 2022-06-30 | -$1.10 10-Q · filed 2023-08-07 | -$3.08 10-Q · filed 2023-08-07 | ||
| 2022-03-31 | -$1.99 10-Q · filed 2023-05-08 | |||
| 2021-12-31 | -$3.13 10-K · filed 2024-02-26 | |||
| 2021-09-30 | -$0.70 10-Q · filed 2022-11-07 | -$2.18 10-Q · filed 2022-11-07 | ||
| 2021-06-30 | -$0.74 10-Q · filed 2022-08-08 | -$1.48 10-Q · filed 2022-08-08 | ||
| 2021-03-31 | -$0.74 10-Q · filed 2022-05-09 | |||
| 2020-12-31 | -$1.71 10-K · filed 2023-02-27 | |||
| 2020-09-30 | -$0.49 10-Q · filed 2021-11-08 | -$1.18 10-Q · filed 2021-11-08 | ||
| 2020-06-30 | -$0.37 10-Q · filed 2021-08-09 | -$0.68 10-Q · filed 2021-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |